Celluma MYSTIQUE Has Launched: The UK and European Unveiling at Cliveden House
On 20 April 2026, S-Thetics Clinic hosted the official UK and European launch of Celluma MYSTIQUE at Cliveden House, Berkshire, with the device’s inventor Patrick Johnson presenting it in person. Here is what happened, what the device is, and how to pre-order yours.
Some product launches happen quietly. This one did not. On the morning of Monday 20 April 2026, guests arrived at Cliveden House in Berkshire to discover that the brand new Celluma device teased in the pre-event communications was Celluma MYSTIQUE: the first LED mask cleared by the FDA to treat the face and the scalp simultaneously, in a single hands-free 30-minute session, at home. Miss Sherina Balaratnam, Medical Director of S-Thetics Clinic and Celluma Global Key Opinion Leader, had selected it for the UK and European market. Its inventor, Patrick Johnson, flew in to introduce it himself.
S-Thetics Clinic is the exclusive UK and European launch partner for MYSTIQUE. It is the only clinic in the UK or Europe currently supplying the device. Pre-orders are now open at the introductory price of £795, with delivery expected by end of May 2026.
The Launch: Cliveden House, 20 April 2026
The event took place in the French Dining Room at Cliveden House, the National Trust property in Berkshire that has hosted Churchill, the Astors, and generations of guests for whom the word “occasion” is not used lightly. It was a deliberate choice: MYSTIQUE is not a consumer gadget. It is a professional-grade, FDA-cleared device, and the setting reflected that.
Guests joined Miss Balaratnam and Patrick Johnson for a morning that moved between clinical briefing, live device demonstration, and extended Q&A. Patrick Johnson, who founded Celluma and whose background spans decades of photobiomodulation research, walked the room through the science of how MYSTIQUE works, why simultaneous three-wavelength delivery matters clinically, and why the scalp arm makes this device categorically different from any other LED mask on the market.
Miss Balaratnam then demonstrated the device live, placing it on a guest and walking through the five treatment modes: Wrinkles, Acne, Hair, Wrinkles plus Hair, and Acne plus Hair. The integrated scalp arm, which extends over the hairline and scalp while the mask covers the face, was the detail that prompted the most questions. It is the feature that makes MYSTIQUE genuinely new: no other FDA-cleared home LED mask treats both simultaneously.
“I have been waiting for a device like this. MYSTIQUE does something no other LED mask on the market can do: it treats the face and the scalp simultaneously, in a single session. That combination of FDA-cleared skin rejuvenation and clinically proven hair restoration, in one hands-free device, is a genuinely significant step forward.”
Miss Sherina Balaratnam · Medical Director, S-Thetics Clinic · Celluma Global Key Opinion Leader
What Is Celluma MYSTIQUE?
MYSTIQUE is a professional-grade LED light therapy mask for home use, FDA-cleared and carrying the Medical CE Mark. It delivers three clinically proven wavelengths simultaneously: 465nm blue light to target acne-causing bacteria, 640nm red light to stimulate collagen synthesis and hair follicle activity, and 880nm near-infrared to reduce inflammation and support circulation at depth. The integrated scalp arm positions therapeutic wavelengths over the hairline and scalp, making simultaneous face and scalp treatment possible in a single 30-minute session.
Five targeted treatment modes allow personalisation: Wrinkles, Acne, Hair, Wrinkles plus Hair, and Acne plus Hair. The device is hands-free and cord-free, designed for consistent home use alongside or between in-clinic treatment.
Miss Balaratnam and Celluma: A Clinical Partnership
S-Thetics Clinic introduced Celluma LED light therapy into its regenerative protocols in 2020. Miss Balaratnam was subsequently appointed Celluma Global Key Opinion Leader, a designation that reflects her clinical application of the technology and her independent evaluation of the evidence base. Her Masters degree from University College London, with research conducted at the National Medical Laser Centre investigating photodynamic therapy, gives her direct academic grounding in the science that underpins MYSTIQUE’s three-wavelength protocol.
Her selection of MYSTIQUE for UK introduction followed the same process applied to every device at S-Thetics: peer-reviewed clinical data, regulatory clearance, and a clear, measurable benefit for patients. MYSTIQUE met all three criteria, and the scalp arm made it the first device to meet them simultaneously for both skin and hair concerns in a single home-use product.
What Celluma MYSTIQUE Treats
The device addresses three primary clinical concerns:
- Skin ageing: fine lines, wrinkles, loss of collagen density and skin firmness. Published protocol: 2-3 sessions per week for 4 weeks minimum.
- Acne: active breakouts and prevention of new lesions using 465nm blue light targeting bacteria at source. Published protocol: 2 sessions per week for 8 weeks.
- Hair restoration: measurable increases in follicle density, strand thickness, and hair count via the integrated scalp arm. The only FDA-cleared home LED mask to offer this indication simultaneously with face treatment. Published protocol: every other day for 12-16 weeks.
Pre-Order Celluma MYSTIQUE at S-Thetics Clinic
MYSTIQUE is available exclusively through S-Thetics Clinic in the UK and Europe. An introductory pre-order price of £795 is available for a limited period, reverting to the standard RRP of £895 once the pre-order window closes. Devices are due for delivery by end of May 2026. Every patient who pre-orders receives a consultation with Miss Balaratnam to confirm the appropriate treatment mode and protocol before the device is issued.
To pre-order, please visit this link or contact the clinic directly. Subject line for email enquiries: Celluma MYSTIQUE Pre-Order Enquiry.
ABOUT THE AUTHOR
Miss Sherina Balaratnam MBBS MRCS(Edin) MSc (UCL) is the Medical Director of S-Thetics Clinic, Beaconsfield, and a qualified Doctor of 26+ years with a 7-year background in NHS reconstructive plastic surgery. She has specialised in aesthetic medicine for 14 years and holds a Masters degree from University College London in surgical science and cancer biology, with research conducted at the National Medical Laser Centre investigating photodynamic therapy.
She is a co-author of the botulinum toxins chapter in the Oxford Textbook of Plastic and Reconstructive Surgery, a Celluma Global Key Opinion Leader, and the first non-US Doctor in BTL’s 32-year history to be appointed as a BTL Global Key Opinion Leader.
S-Thetics Clinic · 45 Wycombe End, Beaconsfield HP9 1LZ · 01494 670990 · info@sthetics.co.uk · sthetics.co.uk